HemoClear aligns with all five strategic goals of the EU’s Stockpiling and Medical Countermeasures Strategies, directly supporting Europe’s crisis readiness and health security.


1️⃣ Threat Intelligence & Early Response
Our equipment and electricity free autologous blood transfusion solution enhances clinical resilience in disaster zones and outbreak scenarios.

2️⃣ Accelerating Medical Countermeasures (MCM)
By enabling donation-independent blood transfusion and positioning convalescent plasma as a frontline treatment in future pandemics, HemoClear provides a scalable and innovative approach to lifesaving interventions.

3️⃣Agile Manufacturing
HemoClear is manufacturing-ready for rapid scale-up and partnerships.

4️⃣Stockpiling & Procurement
As a non-perishable, storable device, it fits perfectly into joint procurement strategies for future readiness.

5️⃣Civilian-Military Coordination & Training
Versatile across sectors, HemoClear builds capacity and empowers decentralised preparedness through a straightforward blood processing procedure.

One innovation, five strategic impacts.